Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance

  • Jacqueline López1,
  • Adela Poitevin2,
  • Veverly Mendoza-Martínez4,
  • Carlos Pérez-Plasencia3 and
  • Alejandro García-Carrancá4Email author
BMC Cancer201212:48

DOI: 10.1186/1471-2407-12-48

Received: 27 June 2011

Accepted: 28 January 2012

Published: 28 January 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jun 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Aug 2011 Reviewed Reviewer Report - Chann Lagadec
10 Aug 2011 Reviewed Reviewer Report - Lyuba Varticovski
11 Aug 2011 Reviewed Reviewer Report - Luis Benítez-Bribiesca
Resubmission - Version 3
Submitted Manuscript version 3
12 Sep 2011 Author responded Author comments - ALEJANDRO GARCIA CARRANCA
Resubmission - Version 4
12 Sep 2011 Submitted Manuscript version 4
4 Oct 2011 Reviewed Reviewer Report - Luis Benítez-Bribiesca
7 Oct 2011 Reviewed Reviewer Report - Lyuba Varticovski
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
28 Jan 2012 Editorially accepted
28 Jan 2012 Article published 10.1186/1471-2407-12-48

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Programa de Doctorado en Ciencias Bioquímicas, Facultad de Química, Universidad Nacional Autónoma de México
(2)
Hospital Médica Sur, Unidad de Radioterapia
(3)
Laboratorio de Oncología Genómica, Instituto Nacional de Cancerología & UBIMED-FESI, Universidad Nacional Autónoma de México
(4)
Unidad de Investigación Biomédica en Cáncer, División de Investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud & Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México

Advertisement